PREVALENCE OF DIABETIC RETINOPATHY IN PATIENT TYPE 2 DIABETES MELLITUS AT INTERNAL MEDICINE POLICLINIC SANGLAH HOSPITAL
on
Authors:
Ni Made Sintia Anggia Sari, Made Ratna Saraswati
Abstract:
“One of the complications that can occur in microvaskular diabetes mellitus is diabetic retinopathy. This research was carried out to know the prevalence of diabetic retinopathy in patients type 2 diabetes mellitus at internal divison of Sanglah Hospital. The method used is cross sectional by collecting data from the questionnaire and secondary data of medical record patient’s type 2 DM. On this research acquired 111 patients (35.1%) with diabetic retinopathy and (64,9%) nonretinopathy. In the group with good level of HbA1c (<6.5%) the prevalence of diabetic retinopathy obtained 53.2%, in the group of patients with moderate level of HbA1c (6.5-8%) as much as 22.5%, and in the group of patients with HbA1c bad level (>8%) as much as 24.3%. The prevalence of the occurrence of DM complications in the diabetic retinopathy is still high, and a good level of HbA1c does not guarantee a person can’t have complication because the complication can also happens are affected by hypertension, dyslipidemia, age, and duration of DM.”
Keywords
Keyword Not Available
Downloads:
Download data is not yet available.
References
References Not Available
PDF:
https://jurnal.harianregional.com/eum/full-5627
Published
2021-11-09
How To Cite
ANGGIA SARI, Ni Made Sintia; SARASWATI, Made Ratna. PREVALENCE OF DIABETIC RETINOPATHY IN PATIENT TYPE 2 DIABETES MELLITUS AT INTERNAL MEDICINE POLICLINIC SANGLAH HOSPITAL.E-Jurnal Medika Udayana, [S.l.], p. 1090-1099, may 2013. ISSN 2303-1395. Available at: https://jurnal.harianregional.com/eum/id-5627. Date accessed: 08 Jul. 2024.
Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian
Issue
vol 2 no6(2013):e-jurnal medika udayana
Section
Articles
Copyright
This work is licensed under a Creative Commons Attribution 4.0 International License
Discussion and feedback